BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20623332)

  • 1. RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.
    Zhou GW; Hu J; Peng XD; Li Q
    Breast Cancer Res Treat; 2011 Jan; 125(2):529-35. PubMed ID: 20623332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
    Yu KD; Yang C; Fan L; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
    Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
    Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.
    Wang W; Li JL; He XF; Li AP; Cai YL; Xu N; Sun SM; Wu BY
    PLoS One; 2013; 8(9):e75153. PubMed ID: 24040396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.
    Sekhar D; Pooja S; Kumar S; Rajender S
    Sci Rep; 2015 Jun; 5():11588. PubMed ID: 26108708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
    Antoniou AC; Sinilnikova OM; Simard J; Léoné M; Dumont M; Neuhausen SL; Struewing JP; Stoppa-Lyonnet D; Barjhoux L; Hughes DJ; Coupier I; Belotti M; Lasset C; Bonadona V; Bignon YJ; ; Rebbeck TR; Wagner T; Lynch HT; Domchek SM; Nathanson KL; Garber JE; Weitzel J; Narod SA; Tomlinson G; Olopade OI; Godwin A; Isaacs C; Jakubowska A; Lubinski J; Gronwald J; Górski B; Byrski T; Huzarski T; Peock S; Cook M; Baynes C; Murray A; Rogers M; Daly PA; Dorkins H; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Niederacher D; Deissler H; ; Spurdle AB; Chen X; Waddell N; Cloonan N; ; Kirchhoff T; Offit K; Friedman E; Kaufmann B; Laitman Y; Galore G; Rennert G; Lejbkowicz F; Raskin L; Andrulis IL; Ilyushik E; Ozcelik H; Devilee P; Vreeswijk MP; Greene MH; Prindiville SA; Osorio A; Benitez J; Zikan M; Szabo CI; Kilpivaara O; Nevanlinna H; Hamann U; Durocher F; Arason A; Couch FJ; Easton DF; Chenevix-Trench G;
    Am J Hum Genet; 2007 Dec; 81(6):1186-200. PubMed ID: 17999359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
    Wang Z; Dong H; Fu Y; Ding H
    Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
    Levy-Lahad E; Lahad A; Eisenberg S; Dagan E; Paperna T; Kasinetz L; Catane R; Kaufman B; Beller U; Renbaum P; Gershoni-Baruch R
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3232-6. PubMed ID: 11248061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
    Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
    Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for clarification of data in the recent meta-analysis about RAD51 135G>C polymorphism and breast cancer risk.
    He XF; Su J; Zhang Y; Ding DP; Wang W; Liu Y
    Breast Cancer Res Treat; 2011 Sep; 129(2):649-51; author reply 652-3. PubMed ID: 21537934
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.
    Zhang BB; Wang DG; Xuan C; Sun GL; Deng KF
    Fam Cancer; 2014 Dec; 13(4):515-26. PubMed ID: 24859942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
    Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
    Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
    Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.
    Cheng D; Shi H; Zhang K; Yi L; Zhen G
    Diagn Pathol; 2014 Jan; 9():18. PubMed ID: 24457040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
    Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG
    BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects.
    Sun H; Bai J; Chen F; Jin Y; Yu Y; Jin L; Fu S
    Breast Cancer Res Treat; 2011 Jan; 125(1):157-61. PubMed ID: 20454923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk.
    Lu PH; Li C; Zhou HY; Wang T; Chu CQ; Shen W; Tao GQ
    Breast Cancer Res Treat; 2011 Jan; 125(1):299-300. PubMed ID: 20878355
    [No Abstract]   [Full Text] [Related]  

  • 19. 135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis.
    Wu L; Long ZG; Dai ZS
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
    Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.